Biogen (BIIB) PT Raised to $408 at Cowen

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. GOOGL
5. APGE
6. MU
7. HOOD
8. DFTX
9. USO
10. MSFT

Go back to Biogen (BIIB) PT Raised to $408 at Cowen

Biogen (BIIB) PT Raised to $400 at Oppenheimer

January 26, 2018 6:46 AM EST

Oppenheimer raised its price target on Biogen (NASDAQ: BIIB) to $400.00 (from $380.00) while maintaining a Outperform rating.

Analyst Jay Olson commented, "BIIB shares outperformed yesterday (+2.1% vs. NBI +0.7% and S&P 500 +0.1%) on strong 4Q17 financial results and confidence expressed by management regarding execution on key... More

Biogen (BIIB) PT Raised to $403 at BMO Capital on 4Q Report; '2018 Guidance Above Street With Room to Grow'

January 25, 2018 3:48 PM EST

BMO Capital raised its price target on Biogen (NASDAQ: BIIB) to $403.00 (from $394.00) while maintaining a Outperform rating, following the company's fourth quarter earnings report.

Analyst M. Ian Somaiya notes a positive outlook on the shares, as the company reported fourth quarter revenues above... More

Biogen (BIIB) Misses Q4 EPS by 19c, Revenue Beats; Offers Outlook

January 25, 2018 6:31 AM EST

(Updated - January 25, 2018 6:33 AM EST)

Biogen (NASDAQ: BIIB) reported Q4 EPS of $5.26, $0.19 worse than the analyst estimate of $5.45. Revenue for the quarter came in at $3.31 billion versus the consensus estimate of $3.08 billion.

GUIDANCE:

Biogen sees FY2018 EPS of $24.20-$25.20... More